If you are a KinderCare investor and would like to learn more about this action, CLICK HERE  or please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Caitlin Adorni at [email protected] or (267)764-4865. About Berger Montague Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto, has been a pioneer in securities class action litigation since its founding in 1970. Berger Mo ...

PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Sina Corporation (Other: SINA) (“Sina” or the “Company”) on behalf of investors who sold Sina shares, including those that sold into Sina’s go-private merger, during the period from October 13, 2020 through March 22, 2021 (the “Class Period”). Investor Deadline: Investors who sold SINA securities during the Class Period may, no later than November 18, 2025, seek to be app ...

, /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025, seek to be appointed as a lead plaintiff representative of the class. To lea ...

Core Viewpoint - Rosen Law Firm is reminding purchasers of KinderCare Learning Companies, Inc. common stock about the upcoming lead plaintiff deadline for a class action lawsuit related to the company's October 2024 IPO [1]. Group 1: Class Action Details - Investors who purchased KinderCare common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 14, 2025 [3]. - The lawsuit claims that the registration statement was false and/or misleading, failing to disclose incidents of child abuse and neglect at KinderCare facilities, which exposed the company to material risks [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in recovering hundreds of millions for investors [4]. - The firm has been recognized for its performance in securities class action settlements, achieving the largest settlement against a Chinese company at the time and ranking highly in the industry since 2013 [4].

Core Viewpoint - A class action lawsuit has been filed against Novo Nordisk A/S by Berger Montague PC on behalf of investors who acquired Novo's publicly traded securities during the specified class period from May 7, 2025, to July 28, 2025 [1][2] Company Summary - Novo Nordisk A/S is a global pharmaceutical company headquartered in Denmark [3] - The lawsuit alleges that Novo understated the impact of the personalization exception to the compounded GLP-1 exclusion, which has allowed continued use of compounded alternatives to its products [3] - The company is accused of overstating the likelihood that patients using less expensive compounded drugs would switch to its branded products, leading to an overestimation of its long-term growth potential [3] Financial Impact - On July 29, 2025, Novo announced a reduction in its sales and profit outlook for fiscal 2025, citing slower-than-expected growth for its products Wegovy® and Ozempic® due to competition from compounded GLP-1 products [4] - Following this announcement, Novo's stock price fell from $69.00 per share on July 28, 2025, to $53.94 per share on July 29, representing a decline of approximately 21.83% in a single day [4]

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities as well as purchasers of call options or sellers of put options of Charter Communications, Inc. (NASDAQ: CHTR) between July 26, 2024 and July 24, 2025, both dates inclusive (the “Class Period”), of the important October 13, 2025 lead plaintiff deadline. SO WHAT: If you purchased Charter Communications securities during the Class Period you may be entitled to compensation wit ...

Core Viewpoint - A class action lawsuit has been filed against KBR, Inc. by Berger Montague on behalf of investors who acquired KBR shares between May 6, 2025, and June 19, 2025, due to undisclosed concerns regarding a key military contract [1][3]. Group 1: Lawsuit Details - The lawsuit alleges that KBR failed to disclose material concerns from the U.S. Department of Defense's Transportation Command (TRANSCOM) regarding HomeSafe's ability to fulfill the Global Household Goods Contract [3]. - KBR reassured investors that the contract would proceed as expected, despite being aware of the issues within the partnership [3]. - Following the disclosure of the contract termination by HomeSafe on June 19, 2025, KBR's shares dropped by $3.85, or 7%, closing at $48.93 on June 20, 2025 [4]. Group 2: Company Background - KBR, Inc. is a Houston-based firm specializing in engineering, technology, and government services, providing logistics and operations support to various federal agencies, including the Department of Defense [2].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Lineage, Inc. common stock during its July 2024 IPO about the September 30, 2025 deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Lineage common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court by September 30, 2025, to serve as lead plaintiff [3] - The lawsuit claims that the registration statement was misleading, failing to disclose significant issues affecting Lineage's business operations and financial results [5] Group 2: Allegations Against Lineage - The lawsuit alleges that Lineage experienced a decline in customer demand due to increased cold-storage supply and destocking of excessive inventory built during the COVID-19 pandemic [5] - It is claimed that Lineage implemented unsustainable price increases prior to the IPO, which could not be maintained in the face of weakening demand [5] - The company reportedly could not counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or falling revenue, occupancy rates, and rent prices [5] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been ranked highly for its performance in securities class action settlements [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of RxSight, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - The class action lawsuit has been filed against RxSight, and investors who purchased securities between May 7, 2024, and July 8, 2025, may be entitled to compensation without any out-of-pocket fees [1][2] - Investors wishing to serve as lead plaintiff must file a motion with the Court by September 22, 2025 [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3] Group 3: Case Allegations - The lawsuit alleges that RxSight misrepresented the performance of its field organization and the adoption rates of newer customer cohorts, leading to inflated stock prices [4] - It is claimed that the actual utilization across the installed base was declining, contradicting the company's statements about growth and support [4]

Core Viewpoint - A class action lawsuit has been filed against KinderCare Learning Companies, Inc. for allegedly misleading investors during its IPO period, particularly regarding the quality of care provided at its facilities [1][3][4]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased shares from October 6, 2024, to August 12, 2025, including during the October 2024 IPO [1][2]. - Investors have until October 14, 2025, to seek appointment as lead plaintiff representatives [2]. Group 2: Allegations - The investigation centers on claims that the IPO registration statement contained false and misleading information, failing to disclose incidents of child abuse and neglect at KinderCare facilities [3]. - It is alleged that KinderCare did not meet minimum care standards or legal compliance requirements, contradicting claims of providing "the highest quality care possible" [3]. Group 3: Financial Impact - Since the IPO, KinderCare's shares have significantly declined, reaching lows near $9 per share, resulting in substantial losses for investors [4].